Fig. 1From: The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching studyOverall survival and cancer-specific survival. a Three (11.5%) and sixteen (20.4%) patients died in the IAC and NIAC groups, respectively (p = 0.354). b Two (7.7%) and eleven (14.1%) patients suffered cancer-specific mortality in the IAC and NIAC groups, respectively (p = 0.439)Back to article page